A. Sáenz

981 citations

19 papers · 549 indexed · h-index 9

Impact in

Surgery top 10%
- Testicular diseases and treatments
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
Rheumatology top 10%
- Urologic and reproductive health conditions

Papers in ⓘ

Surgery 12
- Testicular diseases and treatments 9
- Bladder and Urothelial Cancer Treatments 2
- Urinary and Genital Oncology Studies 2
Pulmonary and Respiratory Medicine 6
- Sarcoma Diagnosis and Treatment 2

Co-authors: Joan Carles (6 shared papers)Begoña Mellado (3 shared papers)Albert Font (2 shared papers)Xavier García del Muro (8 shared papers)Jorge Aparicio (9 shared papers)Josep Gumà (6 shared papers)Pablo Maroto (7 shared papers)M. López-Brea (2 shared papers)
Journals: Journal of Clinical Oncology (7 papers)Annals of Oncology (3 papers)European Journal of Cancer (2 papers)Cancer (1 paper)Clinical & Translational Oncology (1 paper)
Partner nations: Spain

In The Last Decade

A. Sáenz

19 papers receiving 542 citations

Peers

Countries citing papers authored by A. Sáenz

Since Specialization

Citations

This map shows the geographic impact of A. Sáenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sáenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sáenz more than expected).

Fields of papers citing papers by A. Sáenz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sáenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sáenz. The network helps show where A. Sáenz may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Sáenz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Sáenz Line = papers co-authored together A. Sáenz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study Journal of Clinical Oncology ·Jorge Aparicio, J.R. Germà, Xavier García del Muro, Pablo Maroto, José Ángel Arranz, A. Sáenz, Agustín Barnadas, Joan Dorca, Josep Gumà, David Olmos, R. Bastús, Joan Carles, D. Almenar, M.A. Sánchez-Granero, Luis Paz‐Ares, Juan J. Satrústegui, Begoña Mellado, A. Balil, M. López-Brea, Alfredo Sánchez	2005	134
2	Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium Journal of Clinical Oncology ·Joaquim Bellmunt, Vicente Guillém, Luis Paz‐Ares, J.L. González-Larriba, Joan Carles, E. Batiste-Alentorn, A. Sáenz, M. López-Brea, Albert Font, Miguel Nogué, R. Bastús, José A. Martínez-Climent, Juan J. de la Cruz, Joan Albanell, J.M. Banús, Enrique Gallardo, Eduardo Díaz‐Rubio, H. Cortés-Funes, José Baselga, (unknown)	2000	134
3	Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract Cancer ·Miquel Nogué‐Aliguer, Joan Carles, A. Arriví, Óscar Juan, Lorenzo Alonso, Albert Font, Begoña Mellado, Pilar Garrido, A. Sáenz	2003	83
4	Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma Annals of Oncology ·Jorge Aparicio, Xavier García del Muro, Pablo Maroto, Luis Paz‐Ares, Emilio Alba, A. Sáenz, Josefa Terrasa, Agustí Barnadas, D. Almenar, José Ángel Arranz, Miguel A. Sánchez, António Fernández, Javier Sastre, Joan Carles, Joan Dorca, Josep Gumà, A. Yuste, J.R. Germà	2003	78
5	Phase II Trial of Preoperative Irinotecan–Cisplatin Followed by Concurrent Irinotecan–Cisplatin and Radiotherapy for Resectable Locally Advanced Gastric and Esophagogastric Junction Adenocarcinoma International Journal of Radiation OncologyBiologyPhysics ·Fernando Rivera, Maica Galán, Josep Tabernero, Andrés Cervantes, M. E. Vega-Villegas, Javier Gállego, Berta Laquente, Edith Rodríguez, Alfredo Carrato, P. Escudero, Bartomeu Massutí, Vicente Alonso-Orduña, Adelaida Cardenal, A. Sáenz, J. Giralt, Ana Yuste, Antonio Antón, Enrique Aranda	2009	31
6	E400P in advanced seminoma of good prognosis according to the International Germ Cell Cancer Collaborative Group (IGCCCG) classification: The Spanish Germ Cell Cancer Group experience Annals of Oncology ·J.Á. Arranz Arija, Xavier García del Muro, Josep Gumà, Jorge Aparicio, Ramón Salazar, A. Sáenz, Joan Carles, Miguel A. Sánchez, Josep Ramón Germà-Lluch	2001	18
7	Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines Annals of Oncology ·Juan Luis Gomez Marti, P. Bueso, José Mayordomo, Dolores Isla, A. Sáenz, P. Escudero, Laura Murillo, Elena Filipovich, R. Andrés, A. Trés	2001	15
8	Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base Clinical & Translational Oncology ·(unknown), Regina Gironés, Jorge Aparicio, P. Roure, J. R. Germa-Lluch, Xavier García del Muro, Sergio Vázquez‐Estévez, A. Sáenz, Javier Sastre, J.Á. Arranz Arija, Enrique Gallardo, Enrique González‐Billalabeitia, Alfredo Sánchez-Hernández, Josefa Terrasa, Amaia Hernández, Carmen Santander, Elena Cillán, N. Sagastibelza, D. Almenar‐Cubells, Marta López Brea, Pablo Maroto	2014	15
9	Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer European Journal of Cancer ·Vicente Alonso, P. Escudero, Miriam Zorrilla, Dolores Isla, Ana Herrero, José Mayordomo, Javier Martínez‐Trufero, A. Sáenz, A. Trés, A. Antón	2001	13
10	Patrón clínico y resultados terapéuticos obtenidos en el tumor germinal testicular en España a partir de una serie consecutiva de 1.250 pacientes Medicina Clínica ·J.R. Germà, Xavier García del Muro, Pablo Maroto, P. Lianes, José Ángel Arranz, Josep Gumà, Jorge Aparicio, Javier Sastre, Emilio Alba, Josefa Terrasa, A. Sáenz, António Fernández	2001	6
11	Risk-adapted management of stage I seminoma: The second Spanish Germ Cell Cancer Group (GG) study Journal of Clinical Oncology ·Jorge Aparicio, J. R. Germa, Xavier García del Muro, Pablo Maroto, J. A. Arranz, A. Sáenz, A. Barnadas, Joan Dorca, Emilio Alba	2004	5
12	Gemcitabine(G)/erlotinib(E) versus gemcitabine/erlotinib/capecitabine(C) in the first-line treatment of patients with metastatic pancreatic cancer (mPC): Efficacy and safety results of a phase IIb randomized study from the Spanish TTD Collaborative Group. Journal of Clinical Oncology ·Manuel Benavides, Javier Gállego, Carmen Guillén‐Ponce, Ruth Vera, Vega Iranzo, Inmaculada Alés Díaz, Sara Arevalo, A. Pisa, Marta Martín-Richard, Antonieta Salud Salvia, E. Falcó, A. Sáenz, José Luís Zamora Manzano, Gema Pulido, Joaquina Martínez-Galán, R.A. Pazo Cid, Fernando Rivera, Teresa García, Antonio Irigoyen López, Enrique Aranda	2014	5
13	Phase II Trial of Oral Tegafur and Folinic Acid with Mitoxantrone as First-Line Regimen in Patients with Metastatic Breast Cancer Tumori Journal ·Vicente Alonso, Carmen Santander, Jesús Florián, M. Alonso, Dolores Isla, P. Escudero, A. Sáenz, A. Trés	1996	4
14	Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma Cancer Chemotherapy and Pharmacology ·(unknown), Fernando Rivera, Maica Galán, Josep Tabernero, Andrés Cervantes, Ma Eugenia Vega-Villegas, Javier Gállego, Berta Laquente, Edith Rodríguez, Alfredo Carrato, P. Escudero, Bartomeu Massutí, Vicente Alonso-Orduña, Adelaida Cardenal, A. Sáenz, J. Giralt, Ana Yuste, Antonio Antón, Enrique Aranda	2010	2
15	Comparing diagnosis, management, and outcomes of synchronous versus metacrhonus brain metastases from testicular germ cell tumors (TGCT): Multinstitutional experience from the Spanish Germ Cell Cancer Group (SGCCG). Journal of Clinical Oncology ·Jorge Aparicio, Regina Gironés, Pere Roure, J. R. Germa-Lluch, Sergio Vázquez‐Estévez, A. Sáenz, Javier Sastre, Jóse Ángel Arranz Arija, Enrique Gallardo, Enrique González‐Billalabeitia, Alfredo Sánchez-Hernández, Josefa Terrasa, Ana Lluch Hernández, Carmen Santander, Elena Cillán, N. Sagastibelza, D. Almenar‐Cubells, Marta López Brea, Pablo Maroto, (unknown)	2013	2
16	884 Long-term results following one course of adjuvant chemotherapy for high-risk stage I non-seminomatous germ cell tumors: the Spanish germ cell cancer group experience European Journal of Cancer Supplements ·Xavier García del Muro, Pablo Maroto, A. Barnadas, Josefa Terrasa, A. Sáenz, M. Lomas, Javier Valdivia, E. Batiste-Alentorn, G. Berenguer, Josep Ramón Germà-Lluch	2003	1
17	E400P in good prognosis advanced seminoma. The Spanish germ-cell cancer group experience European Journal of Cancer ·José Ángel Arranz, Xavier García del Muro, Josep Gumà, Jorge Aparicio, Ramón Salazar, A. Sáenz, Joan Carles, M. Martín Sánchez, J.R. Germà	1999	1
18	Prognostic significance of thromboembolic events in chemotherapy-treated germ cell tumors. Journal of Clinical Oncology ·Enrique González‐Billalabeitia, Josep Gumà, Daniel Castellano, Maria Isabel Luengo, Jorge Aparicio, Alfonso Sánchez Muñoz, Begoña Mellado, A. Sáenz, Claudia Valverde, António Fernández, Mireia Margelí Vila, Ignacio Durán, Sara Fernandez Arrojo, Javier Sastre, Silverio Ros, J.P. Maroto Rey, Alberto Carmona‐Bayonas, Francisco Ayala, David Hervás, J. R. Germa-Lluch, (unknown)	2015	1
19	Predictive value of Serum S-100B protein in predicting relapse in patients with melanoma Journal of Clinical Oncology ·Rodrigo Pimienta Lastra, Raquel Andrés, José Mayordomo, E. Ortega, J. Lambea, R. Lara, E. Polo, A. Sáenz, (unknown), A. Trés	2004	1

About A. Sáenz

A. Sáenz is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Rheumatology, Oncology and Molecular Biology, having authored 19 papers that have together received 549 indexed citations. Recurring topics across this work include Testicular diseases and treatments (9 papers), Urologic and reproductive health conditions (6 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Urinary and Genital Oncology Studies (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Surgery (482 citations), Rheumatology (152 citations), Reproductive Medicine (49 citations), Pulmonary and Respiratory Medicine (166 citations) and Neurology (73 citations). A. Sáenz has collaborated with scholars based in Spain. Frequent co-authors include Joan Carles, Begoña Mellado, Albert Font, Xavier García del Muro, Jorge Aparicio, Josep Gumà, Pablo Maroto, M. López-Brea, R. Bastús and Joan Dorca. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer and Clinical & Translational Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact